medric medric
[닫기]
잠시만 기다려 주세요. 로딩중입니다.

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C

Clinical and Molecular Hepatology 2019년 25권 3호 p.234 ~ 244
 ( Na Seong-Kyun ) - Jeju National University School of Medicine Department of Internal Medicine

 ( Song Byung-Cheol ) - Jeju National University School of Medicine Department of Internal Medicine

Abstract


Hepatitis C virus (HCV) infection is a major risk factor for liver cirrhosis and hepatocellular carcinoma (HCC), and is a leading cause of liver-related deaths worldwide. Recently available direct-acting antiviral agent is very safe and highly effective (>95% sustained virologic response, SVR) against all genotypes of HCV. Achievement of SVR has been associated with a significant reduction of hepatic decompensation, development of HCC, and liver-related mortality. However, HCC risk is not eliminated even after SVR. The annual incidences of HCC in advanced fibrosis or cirrhosis have been estimated to be up to 2.5?4.5% even in patients with SVR. Therefore, surveillance for HCC is recommended in this high-risk patients. In this review, we will describe the clinical outcomes and the risk of HCC in patients with SVR and suggest who should receive surveillance for HCC.

키워드

Chronic hepatitis C; Sustained virologic response; Hepatocellular carcinoma
원문 및 링크아웃 정보
 
등재저널 정보